Status:
COMPLETED
Colchicine Has Anti-diabetic Effect
Lead Sponsor:
Ministry of Health and Population, Egypt
Conditions:
Treatment Adherence
Eligibility:
All Genders
35-55 years
Brief Summary
Colchicine has antidiabetic effect and may be an option for type 2 diabetes management
Detailed Description
Observational cohort prospective study with following of 150 newly diagnosed type 2 diabetes patients who were in 3 groups, had been monitored in a private clinic, each group 50 patients number, with ...
Eligibility Criteria
Inclusion
- type 2 diabetes newly diagnosed age 35- 55 years
Exclusion
- severe anemia hypothyroidism and hyperthyroidism moderate to severe liver or kidney disease
Key Trial Info
Start Date :
October 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04377321
Start Date
October 10 2019
End Date
May 2 2020
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud Younis
Cairo, Egypt, 11865